CE Credit Hours: 2.00 Continuing Education Credit Hours
CEU Course Description
This intermediate level continuing education course. developed using information from The University of South Florida, Florida Medicaid Drug Therapy Management Program, gives a brief overview of evidence-based recommendations for prescribing psychotherapeutic medication to treat severe mental illness. Principles of practice to guide clinicians are presented as well as specific considerations when using medications to treat schizophrenia, major depression, bipolar disorder, and mood disorders in pregnancy. Strategies to incorporate assessment and evaluation into routine clinical practice are included as well as guidelines for achieving optimal outcomes with currently available medications.
CEU Course Objectives
1 Summarize general principles of clinical practice for treating severe mental illness as well as the primary goals of care for various disorders.
2. Identify psychiatric medications that are most often prescribed for treating schizophrenia, major depression, bipolar disorder, and mood disorders in pregnancy.
3. Understand important differences between classes of medications used for treating these conditions.
4. Discuss ways to incorporate assessment and evaluation into routine clinical practice.
5. Outline guidelines for achieving optimal outcomes with currently available medications.
6. Determine the level of efficacy, tolerance, and safety for various psychotherapeutic medications.
The Mindful team consists of numerous behavioral health professionals with a plethora of clinical experience as well as backgrounds in higher education, including teaching at the university level. Our three consulting psychologists review the appropriate course material, based on their experience and expertise that aligns with program content, to ensure that it enhances interdisciplinary understanding and is consistent with a systematic, research-based approach to promoting continued education and for synthesizing new knowledge into the clinician’s professional environment.
Did you know you can now get UNLIMITED Continuing Education Credit Hours for only $95/year?
Click Here to learn more.
Course Date: 2019-02-01
Our courseware includes the text content found on our websites as well as video, audio, and exam questions that make up our courses. You can link to and access our courseware free of charge for personal use. You may not modify or redistribute our courseware under any circumstances.
Although we allow free access for personal use, you may not use our courseware for any commercial purposes without an agreement in place. This includes (but is not limited to) using our courseware for internal training, redistributing our courseware for sale, and copying all or parts of any of our courseware.
If you're interested in licensing our content for commercial purposes or have any other questions, please contact firstname.lastname@example.org.
We will disclose, in advance, any proprietary interest in any product, instrument, device, service, or material to be discussed during the learning event, as well as the source of any third-party compensation related to the presentation. This policy applies to both our organization and contractors. If such proprietary/financial interests exist, we will publish a disclaimer in marketing or instructional materials for a course.
No conflict of interest was identified for this learning activity for individuals in a position to control content.
In order to view this course, you will need to be able to view a PDF document for the course material. If your device doesn't have the capability to view a PDF, you can click here to download Adobe Acrobat for free.
If you require ADA or other special needs accommodations, please contact us by email: email@example.com or by phone 1-800-413-3797, so arrangements can be made.
The board approval status information is provided based on our current understanding of the licensing agencies. Please note that it is the responsibility of each licensee to verify acceptance of our courses with their licensing agency.